UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000021773
Receipt No. R000025113
Official scientific title of the study The study for the prevalence of HIV-associated neurocognitive disorder (HAND) in HIV-infected hemophilia
Date of disclosure of the study information 2016/05/01
Last modified on 2019/02/22 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The study for the prevalence of HIV-associated neurocognitive disorder (HAND) in HIV-infected hemophilia
Title of the study (Brief title) Hemophilia/HAND study
Region
Japan

Condition
Condition Hemophilia, HIV infection
Classification by specialty
Hematology and clinical oncology Neurology Infectious disease
Psychiatry
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 An evaluation of the prevalence of HIV-associated neurocognitive disorder in HIV-infected hemophilia
Basic objectives2 Others
Basic objectives -Others Neuropsychological evaluation of HIV-infected hemophilia
Trial characteristics_1 Others
Trial characteristics_2 Others
Developmental phase Not applicable

Assessment
Primary outcomes The prevalence of HIV-associated neurocognitive disorder in HIV-infected hemophilia
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria (1) HIV-infected hemophilia
(2) Older than 20 years old
(3) Written informed consent
Key exclusion criteria (1) Active AIDS-defining disease
(2) Congenital developmental retardation
(3) Definitive diagnosis of following diseases
a. Mental disorder: major depressive disorder, schizophrenia
b. Alzheimer's disease, Frontotemporallobar degeneration, Lewy-body disease, Vascular disease, Traumatic brain injury, Prion disease, Parkinson's disease, Huntington's disease
c. Another functional neurocognitive disorder
d. Illegal substance use
e. Severe alcoholism
f. Endocrine disorder : hypothyroidism, Wernicke encephalopathy, Vitamin B12 deficiency
g. Current treatment or severe sequelae of CNS opportunistic infections
h. Symptoms of a current, active infection a body temperature of >38.5 at the time of recruitment
(4) Experience of neuropsychiatric test within past 1 year
(5) Other inappropriate condition for neuropsychiatric test
Target sample size 50

Research contact person
Name of lead principal investigator Koubun Imai
Organization National Center for Global Health and Medicine
Division name Department of Psychiatry
Address 1-21-1, Toyama, Shinjuku-ku, Tokyo
TEL 03-3202-7181
Email koimai@hosp.ncgm.go.jp

Public contact
Name of contact person Koubun Imai
Organization National Center for Global Health and Medicine
Division name Department of Psychiatry
Address 1-21-1, Toyama, Shinjuku-ku, Tokyo
TEL 03-3202-7181
Homepage URL
Email koimai@hosp.ncgm.go.jp

Sponsor
Institute National Center for Global Health and Medicine
Institute
Department

Funding Source
Organization Ministry of Health, Labour and Welfare
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor AIDS Clinical Center, National Center for Global Health and Medicine
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 国立国際医療研究センター(東京都)

Other administrative information
Date of disclosure of the study information
2016 Year 05 Month 01 Day

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 03 Month 22 Day
Anticipated trial start date
2016 Year 05 Month 01 Day
Last follow-up date
2017 Year 12 Month 31 Day
Date of closure to data entry
2018 Year 01 Month 31 Day
Date trial data considered complete
2018 Year 02 Month 28 Day
Date analysis concluded
2018 Year 03 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Neuropsychiatric examination, mental symptoms

Management information
Registered date
2016 Year 04 Month 04 Day
Last modified on
2019 Year 02 Month 22 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000025113